Cantor Fitzgerald analyst Thomas Blakey reiterated a Hold rating on Atlassian (TEAM – Research Report) yesterday and set a price target of ...
Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the field ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback